Ginkgo Bioworks -CW27DNABWPreferred / convertible
13F holders, Q4 2024 (December 31)3holders −2
0new positions
2sold out
$0.01avg. 13F price*
At the end of Q4 2024, 3 institutions reported holding Ginkgo Bioworks -CW27 (DNABW) in their 13F filings, down 2 from Q3 2024. 0 opened new positions and 2 sold out. The largest holders were Altshuler Shaham Ltd ($4K), Harbor Investment Advisory, LLC ($1) and NewSquare Capital LLC ($1).
- Company
- Ginkgo Bioworks -CW27
- CUSIP
- 37611X118
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $292 |
All 13F filers, Q3 2024 → Q4 2024: 64,909 shares sold, net −64,909 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Altshuler Shaham Ltd | — | No change | 576,345 | $4K |
| Harbor Investment Advisory, LLC | — | No change | 140 | $1 |
| NewSquare Capital LLC | — | No change | 60 | $1 |
"% of holder's portfolio" is DNABW's weight in each manager's 13F, not the share of Ginkgo Bioworks -CW27 the manager owns.